RICHMOND, Va.--(BUSINESS WIRE)--
Owens & Minor, Inc. (NYSE:OMI) today announced that its board of
directors has elected two healthcare industry veterans to serve on the
company's board, effective October 30, 2013. The new board members are:
Stuart M. Essig, 52, the former chief executive officer and current
board chairman of Integra LifeSciences Holdings Corporation (NASDAQ:
IART); and David S. Simmons, 49, chairman & chief executive officer of
Pharmaceutical Product Development, LLC.
"These two healthcare industry experts will bring added depth and
breadth to our board, as we position Owens & Minor for growth in an
increasingly globalized healthcare industry," said Craig R. Smith,
chairman & chief executive officer of Owens & Minor. "We look forward to
leveraging the extensive knowledge and experience they have gained from
working for international medical device and pharmaceutical companies.
With their impressive credentials, we believe that both Dr. Essig and
Mr. Simmons will prove to be invaluable additions to our board."
Essig is currently chairman of the board of Integra LifeSciences, where,
as the former chief executive officer, he transitioned the business into
a global surgical products company, growing revenues to more than $830
million from $15 million during his 14-year tenure. Essig also currently
serves as a managing partner of Prettybrook Partners and as chairman of
the board of directors of Breg, Inc., a portfolio company of Water
Street Healthcare Partners, LLC. In addition, Essig also serves on the
board of St. Jude Medical, Inc. (NYSE: STJ). A founding investor member
of Tigerlabs, a Princeton-based accelerator, he is currently an
executive in residence at Cardinal Partners and a venture partner at
Wellington Partners Advisory AG, both venture capital firms, and is a
senior advisor to TowerBrook Capital Partners. Previously, Essig served
on the board of directors of Zimmer Holdings, Inc., and Vital Signs,
Inc. Prior to joining Integra LifeSciences, Essig was a managing
director in mergers and acquisitions for the Goldman Sachs Group, Inc.,
specializing in the medical device, pharmaceutical and biotechnology
sectors. After earning his undergraduate degree from Princeton
University, Essig then earned an M.B.A. and a Ph.D. in financial
economics from the University of Chicago.
Simmons is currently the chairman & chief executive officer of
Pharmaceutical Product Development, LLC. Simmons has served the company,
a leading global contract pharmaceutical research organization, since
2012. Simmons joined Pharmaceutical Product Development after spending
15 years with Pfizer, Inc. During his tenure with Pfizer, Simmons honed
his international and management experience through a variety of
executive management positions in Europe and Canada, last serving as
president and general manager of the emerging markets and established
products business units. Simmons is a graduate of Carnegie-Mellon
University.
Along with the other members of the board, Essig and Simmons are
expected to be nominated for election by the shareholders at Owens &
Minor's April 2014 Annual Meeting of Shareholders. The Owens & Minor
board of directors amended the corporation's bylaws to expand the number
of board seats from 9 to 11 to accommodate the new board members.
Owens & Minor, Inc.,
(NYSE:OMI) a FORTUNE 500 company headquartered in Richmond,
Virginia, is a leading national provider of distribution and logistics
services to the healthcare industry and a leading European provider of
logistics services to pharmaceutical, life-science, and medical-device
manufacturers. With a diverse product and service offering and
facilities throughout the United States and Europe, the company serves
hospitals, integrated healthcare systems, alternate site locations,
group purchasing organizations, healthcare manufacturers, and the
federal government. Owens & Minor also provides technology and
consulting programs that improve inventory management and streamline
logistics across the entire medical supply chain. For news releases, or
for more information about Owens & Minor, visit the company website at www.owens-minor.com.
Owens & Minor
Trudi Allcott, 804-723-7555
Director,
Investor & Media Relations
truitt.allcott@owens-minor.com
Source: Owens & Minor, Inc.
News Provided by Acquire Media